Effects of continuous-combined oral drospirenone- estradiol on blood pressure, body weight & lipid profile in early menopausal women

BACKGROUND & OBJECTIVES: Drospirenone (DRSP) is a progestin with antimineralocorticoid and anti-androgenic activity. When administered in combination with estradiol (E2), it relieves menopausal symptoms. The aim of this study was to evaluate the effects of DRSP/E2 on the reduction of cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Đogo, Aleksandar, Dožić, Branko, Vujović, Svetlana, Srebro, Dragana, Dožić, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347254/
https://www.ncbi.nlm.nih.gov/pubmed/35662091
http://dx.doi.org/10.4103/ijmr.IJMR_478_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347254/
https://www.ncbi.nlm.nih.gov/pubmed/35662091
http://dx.doi.org/10.4103/ijmr.IJMR_478_20

Ejemplares similares